MY102123A - Antidepressant 1,2,4- trazolone compounds - Google Patents
Antidepressant 1,2,4- trazolone compoundsInfo
- Publication number
- MY102123A MY102123A MYPI87002743A MYPI19872743A MY102123A MY 102123 A MY102123 A MY 102123A MY PI87002743 A MYPI87002743 A MY PI87002743A MY PI19872743 A MYPI19872743 A MY PI19872743A MY 102123 A MY102123 A MY 102123A
- Authority
- MY
- Malaysia
- Prior art keywords
- compounds
- trazolone
- antidepressant
- phenoxyyalkyl
- halophenyl
- Prior art date
Links
- 239000000935 antidepressant agent Substances 0.000 title abstract 2
- 229940005513 antidepressants Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000001430 anti-depressive effect Effects 0.000 title 1
- 239000004089 psychotropic agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/538,027 US4613600A (en) | 1983-09-30 | 1983-09-30 | Antidepressant 1,2,4-triazolone compounds |
| GB08424535A GB2147297B (en) | 1983-09-30 | 1984-09-28 | Antidepressant 1,2,4-triazolone compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY102123A true MY102123A (en) | 1992-03-31 |
Family
ID=24145128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI87002743A MY102123A (en) | 1983-09-30 | 1987-10-01 | Antidepressant 1,2,4- trazolone compounds |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4613600A (https=) |
| JP (1) | JPS60100560A (https=) |
| KR (1) | KR880002624B1 (https=) |
| AT (1) | AT387963B (https=) |
| AU (1) | AU561460B2 (https=) |
| BE (1) | BE900714A (https=) |
| CA (1) | CA1237723A (https=) |
| CH (1) | CH661924A5 (https=) |
| CY (1) | CY1541A (https=) |
| DE (1) | DE3435745C2 (https=) |
| DK (1) | DK169546B1 (https=) |
| ES (1) | ES8601966A1 (https=) |
| FI (1) | FI83310C (https=) |
| FR (1) | FR2552759B1 (https=) |
| GB (1) | GB2147297B (https=) |
| GR (1) | GR80475B (https=) |
| HK (1) | HK37391A (https=) |
| IE (1) | IE58084B1 (https=) |
| IT (1) | IT1178522B (https=) |
| LU (1) | LU85561A1 (https=) |
| MY (1) | MY102123A (https=) |
| NL (1) | NL8402946A (https=) |
| SE (1) | SE465928B (https=) |
| YU (1) | YU45667B (https=) |
| ZA (1) | ZA847589B (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4487773A (en) * | 1981-03-16 | 1984-12-11 | Mead Johnson & Company | 1,2,4-Triazol-3-one antidepressants |
| YU44721B (en) * | 1983-11-30 | 1990-12-31 | Bristol Myers Co | Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| US5504086A (en) * | 1989-10-17 | 1996-04-02 | Ellinwood, Jr.; Everett H. | Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone |
| US5256664A (en) * | 1992-04-28 | 1993-10-26 | Bristol-Myers Squibb Company | Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones |
| DE4425144A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Triazolverbindungen und deren Verwendung |
| US6403593B1 (en) | 1995-07-14 | 2002-06-11 | Abbott Laboratories | Triazole compounds and the use thereof |
| DE19728996A1 (de) | 1997-07-07 | 1999-01-14 | Basf Ag | Triazolverbindungen und deren Verwendung |
| JP2002541192A (ja) * | 1999-04-09 | 2002-12-03 | セプラコール， インク． | Ｓ−ヒドロキシネファゾドン |
| US6586437B2 (en) | 1999-04-09 | 2003-07-01 | Sepracor Inc. | (S)-hydroxynefazodone antipsychotic therapy |
| AU4215300A (en) | 1999-04-09 | 2000-11-14 | Sepracor, Inc. | R-hydroxynefazodone |
| US6469008B2 (en) | 1999-04-09 | 2002-10-22 | Sepracor Inc. | (R)-hydroxynefazodone antipsychotic therapy |
| JP4202250B2 (ja) | 2001-07-25 | 2008-12-24 | バイオマリン ファーマシューティカル インコーポレイテッド | 血液脳関門輸送を調節するための組成物および方法 |
| WO2005102366A2 (en) * | 2004-04-19 | 2005-11-03 | Philip Maxwell Satow | Lithium combinations, and uses related thereto |
| EP2671507A3 (en) | 2005-04-28 | 2014-02-19 | Proteus Digital Health, Inc. | Pharma-informatics system |
| MX2009002893A (es) | 2006-09-18 | 2009-07-10 | Raptor Pharmaceutical Inc | Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap). |
| US9339500B2 (en) * | 2008-03-04 | 2016-05-17 | Intra-Cellular Therapies, Inc. | Methods of treating vasomotor symptoms |
| CA2752373C (en) | 2009-02-20 | 2017-10-10 | To-Bbb Holding B.V. | Glutathione-based drug delivery system |
| IL255113B (en) | 2009-05-06 | 2022-09-01 | Laboratory Skin Care Inc | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| WO2012072665A1 (en) | 2010-11-30 | 2012-06-07 | Pharmaneuroboost N.V. | Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors |
| EP2753179A4 (en) * | 2011-09-09 | 2015-03-04 | Univ Leland Stanford Junior | TOPICAL ITRACONAZOLE FORMULATIONS AND THEIR USE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1066857B (it) * | 1965-12-15 | 1985-03-12 | Acraf | Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione |
| IT1052119B (it) * | 1972-10-16 | 1981-06-20 | Sigma Tau Ind Farmaceuti | Derivati del triazolinone e procedimento per la loro preparazione |
| US4338317A (en) * | 1981-03-16 | 1982-07-06 | Mead Johnson & Company | Phenoxyethyl-1,2,4,-triazol-3-one antidepressants |
-
1983
- 1983-09-30 US US06/538,027 patent/US4613600A/en not_active Expired - Lifetime
-
1984
- 1984-09-26 GR GR80475A patent/GR80475B/el unknown
- 1984-09-26 FI FI843779A patent/FI83310C/fi not_active IP Right Cessation
- 1984-09-26 ZA ZA847589A patent/ZA847589B/xx unknown
- 1984-09-27 NL NL8402946A patent/NL8402946A/xx active Search and Examination
- 1984-09-27 ES ES536286A patent/ES8601966A1/es not_active Expired
- 1984-09-28 DE DE3435745A patent/DE3435745C2/de not_active Expired - Lifetime
- 1984-09-28 CH CH4675/84A patent/CH661924A5/de not_active IP Right Cessation
- 1984-09-28 CA CA000464230A patent/CA1237723A/en not_active Expired
- 1984-09-28 JP JP59202142A patent/JPS60100560A/ja active Granted
- 1984-09-28 LU LU85561A patent/LU85561A1/fr unknown
- 1984-09-28 IE IE247684A patent/IE58084B1/en not_active IP Right Cessation
- 1984-09-28 DK DK468284A patent/DK169546B1/da not_active IP Right Cessation
- 1984-09-28 FR FR8414932A patent/FR2552759B1/fr not_active Expired
- 1984-09-28 BE BE0/213750A patent/BE900714A/fr not_active IP Right Cessation
- 1984-09-28 IT IT22922/84A patent/IT1178522B/it active
- 1984-09-28 GB GB08424535A patent/GB2147297B/en not_active Expired
- 1984-09-28 SE SE8404869A patent/SE465928B/sv not_active IP Right Cessation
- 1984-09-28 AU AU33648/84A patent/AU561460B2/en not_active Expired
- 1984-09-29 KR KR1019840006041A patent/KR880002624B1/ko not_active Expired
- 1984-10-01 AT AT0310884A patent/AT387963B/de not_active IP Right Cessation
- 1984-10-05 YU YU172184A patent/YU45667B/sh unknown
-
1987
- 1987-10-01 MY MYPI87002743A patent/MY102123A/en unknown
-
1991
- 1991-03-22 CY CY1541A patent/CY1541A/en unknown
- 1991-05-16 HK HK373/91A patent/HK37391A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY102123A (en) | Antidepressant 1,2,4- trazolone compounds | |
| DK89595A (da) | Fremgangsmåde til fremstilling af 1-(3-dimethylaminopropyl)-1'-(4-fluorphenyl)-1,3-dihydroisobenzofuran-5-carbonnitril | |
| TR200001603T2 (tr) | Yeni bileşikler | |
| BG101198A (en) | Use of 2-[(dihydro)pyrazolyl-3'-oxymethylene]-anilides as pest-control agents and fungicides | |
| DE60143493D1 (de) | 2-Oxo-1-Pyrrolidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung. | |
| TR200000014T2 (tr) | Yeni ikameli imidazol bileşimleri. | |
| NO2001021I1 (no) | Levosimendan | |
| BR9916396A (pt) | Herbicidas | |
| MX9602493A (es) | Aril y heteroaril pirimidinas herbicidas. | |
| BG106930A (en) | Substituted phenyl-piperazine derivatives, their preparation and use | |
| DE69940484D1 (de) | Verwendung von beta-3-adrenergen-Rezeptoren Agonisten in der Behandlung von Dysurie | |
| ATE236153T1 (de) | 4-trifluormethyl-3-oxazolylpyridine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel | |
| ATE178886T1 (de) | 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten | |
| ATE237585T1 (de) | Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung | |
| TR200202195T2 (tr) | 5-Yer değiştirmiş 1-(4-florofenil)-1,3- dihidroizobenzofuran'ın adım adım alkillenmesi | |
| AR227542A1 (es) | Procedimiento para preparar derivados de 4-(4-amino-6,7-dimetoxi-quinazolin-2-il)-1-(2,4-dioxo-2,2,3,4-tetrahidro-pirimidin-6-il)-piperazina | |
| KR960016716A (ko) | 테트라졸리논 | |
| EP0995430A3 (de) | Verwendung von Wirkstoffen, gewählt aus der Gruppe der 1,2-Diacylglycerole, zur Stärkung der Barrierefunktion der Haut | |
| DK1123291T3 (da) | Fremgangsmåde til fremstilling af 3-(substitueret phenyl)-5-thienyl (eller furyl)-1,2,4-triazoler og hidtil ukendte mellemprodukter anvendt derved | |
| ES2001809A6 (es) | Un procedimiento para la preparacion de nuevas 3-(4,-fenil-piperazinil)alquil-quinazolin-2,4-(1h,3h)-dionas sustituidas | |
| DK0847384T3 (da) | Carbamoylcarboxylsyreamider | |
| ATE394105T1 (de) | Substituierte 4,5-dihydro-1,2,4-triazin-3-one, 1, 2,4-triazin-3-one sowie deren verwendung als fungizide und insektizide | |
| ATE207481T1 (de) | Kristallformen von 1-(5-methansulfonamidoindolyl- 2-carbonyl)-4-(3-(1-methylethylamino)-2- pyridinyl) piperazin | |
| EP0885610A4 (en) | Tracheal smooth muscle relaxant | |
| ATE30911T1 (de) | Hydrazinopyridazinverbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |